COMINETTI, DENIS
COMINETTI, DENIS
Dipartimento di Scienze Biomediche e Cliniche
Antitumor activity of a novel homodimeric SMAC mimetic in ovarian carcinoma
2014 L. Gatti, M. De Cesare, E. Ciusani, E. Corna, N. Arrighetti, D. Cominetti, L. Belvisi, D. Potenza, E. Moroni, F. Vasile, D. Lecis, D. Delia, V. Castiglioni, E. Scanziani, P. Seneci, N. Zaffaroni, P. Perego
Comparative assessment of antitumor effects and autophagy induction as a resistance mechanism by cytotoxics and EZH2 inhibition in INI1-negative epithelioid sarcoma patient-derived xenograft
2019 S. Stacchiotti, V. Zuco, M. Tortoreto, D. Cominetti, A.M. Frezza, S. Percio, V. Indio, M. Barisella, V. Monti, S. Brich, A. Astolfi, C. Colombo, S. Pasquali, M. Folini, M.M. Gounder, M.A. Pantaleo, P. Collini, A.P.D. Tos, P.G. Casali, A. Gronchi, N. Zaffaroni
Dacarbazine in solitary fibrous tumor : a case series analysis and preclinical evidence vis-à-vis temozolomide and antiangiogenics
2013 S. Stacchiotti, M. Tortoreto, F. Bozzi, E. Tamborini, C. Morosi, A. Messina, M. Libertini, E. Palassini, D. Cominetti, T. Negri, A. Gronchi, S. Pilotti, N. Zaffaroni, P.G. Casali
Maspin influences response to doxorubicin by changing the tumor microenvironment organization
2014 T. Triulzi, M. Ratti, M. Tortoreto, C. Ghirelli, P. Aiello, V. Regondi, M.D. Modica, D. Cominetti, M.L. Carcangiu, A. Moliterni, A. Balsari, P. Casalini, E. Tagliabue
miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis
2017 R. El Bezawy, D. Cominetti, N. Fenderico, V. Zuco, G. Beretta, M. Dugo, N. Arrighetti, C. Stucchi, T. Rancati, R. Valdagni, N. Zaffaroni, P. Gandellini
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour
2017 S. Stacchiotti, M. Saponara, R. Frapolli, M. Tortoreto, D. Cominetti, S. Provenzano, T. Negri, G.P. Dagrada, A. Gronchi, C. Colombo, B. Vincenzi, G. Badalamenti, V. Zuco, S.L. Renne, P. Collini, C. Morosi, A.P. Dei Tos, E. Bello, S. Pilotti, P.G. Casali, M. D'Incalci, N. Zaffaroni
Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour
2014 S. Stacchiotti, M. Tortoreto, G.G. Baldi, G. Grignani, A. Toss, G. Badalamenti, D. Cominetti, C. Morosi, A.P. Dei Tos, F. Festinese, E. Fumagalli, S. Provenzano, A. Gronchi, E. Pennacchioli, T. Negri, G.P. Dagrada, R.D. Spagnuolo, S. Pilotti, P.G. Casali, N. Zaffaroni
Supersulfated low-molecular weight heparin synergizes with IGF1R/IR inhibitor to suppress synovial sarcoma growth and metastases
2018 G. Cassinelli, L. Dal Bo, E. Favini, D. Cominetti, S. Pozzi, M. Tortoreto, M. De Cesare, D. Lecis, E. Scanziani, L. Minoli, A. Naggi, I. Vlodavsky, N. Zaffaroni, C. Lanzi
Synergistic cooperation between sunitinib and cisplatin promotes apoptotic cell death in human medullary thyroid cancer
2014 A. Lopergolo, V. Nicolini, E. Favini, L. Dal Bo, M. Tortoreto, D. Cominetti, M. Folini, P. Perego, V. Castiglioni, E. Scanziani, M.G. Borrello, N. Zaffaroni, G. Cassinelli, C. Lanzi
Targeting the invasive phenotype of cisplatin-resistant non-small lung cancer cells by a novel histone deacetylase inhibitor
2015 V. Zuco, G. Cassinelli, G. Cossa, L. Gatti, E. Favini, M. Tortoreto, D. Cominetti, E. Scanziani, V. Castiglioni, R. Cincinelli, G. Giannini, F. Zunino, N. Zaffaroni, C. Lanzi, P. Perego